Monday, 20 July 2015

Cardiac Resynchronization Theapy Devices Market in Europe 2015-2019

About Cardiac Resynchronization Therapy Devices According to WHO, cardiovascular diseases accounted for more than half of all deaths in the European region. The annual overall cost of cardiovascular diseases in the top five European countries is estimated to be $90.10 billion, of which 54% is attributed to healthcare costs, 24% to loss in productivity, and 22% to informal care. CRT devices are implantable devices that are used to resynchronize contractions of the heart's ventricles by sending tiny electrical impulses to the muscles of the heart. CRT is an effective therapy for p...more >>

from Infiniti Research Limited Market Research Reports